Prescient Therapeutics Health Care
Cancer Therapeutics

$0.081 0.002 (2.53%)

High $0.09	Low $0.08	Trades 83	Turnover $220,412	Volume 2,818,974
30 June 2023 at 4:10pm

Market Cap (21-Aug) $80,966,624 (780th)	Close (30-Jun) $0.081 0 (0%)	Volume (30-Jun) 2,818,974	Shortsold (14-Apr) 10,996 (0.00%) (617th)
52w High $0.125	52w Low $0.040	P/E 5.48	EPS -0.01

Short Interest

ASIC data, 14 Apr 2026

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

617th

of 697 shorted ASX stocks

Peak Short

0.61%

Jan 2020

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	PTX PTX Ann: Global brain cancer expert joins PTX advisory board
	1 (current) 2 3
	PTX PTX Ann: Investor Presentation
	PTX PTX Ann: June 2021 Quarterly Activities and Appendix 4C
	PTX PTX Ann: PTX-100 trial advances following successful Phase 1b
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Notification regarding unquoted securities - PTX
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Notification regarding unquoted securities - PTX
	PTX PTX Ann: Notification regarding unquoted securities - PTX
	PTX PTX Ann: PTX successful immunogenicity testing of OmniCAR
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: PTX Completes CAR-T Manufacturing Milestone for OmniCAR
	PTX PTX Ann: Response to ASX Price Query
	PTX PTX Ann: Capital Structure Update - Expiry of Unlisted Options
	PTX PTX Ann: PTX signs CAR-T agreement with Peter MacCallum
	PTX PTX Ann: March 2021 Quarterly Update and Appendix 4C
	PTX PTX Ann: PTX-200 AML Trial Progresses to Higher Dose
	PTX PTX Ann: Capital Structure Update - Expiry of Unlisted Options
	PTX PTX Ann: Appendix 4D and Half Year Financial Report
	PTX PTX Ann: December 2020 Quarterly Update and Appendix 4C
	PTX PTX Ann: PTX announces 3 next-gen CAR-T programs with OmniCAR
	PTX PTX Ann: Appendix 3G
	PTX PTX Ann: Change of Director's Interest Notices x4
	PTX PTX Ann: Leading International Blood Cancer Specialist Joins PTX SAB
	PTX PTX Ann: Appendix 3G
	PTX PTX Ann: Issue of Unlisted Options
	PTX PTX Ann: PTX Extends COVID-19 Testing Program with Doherty Institute
	PTX PTX Ann: Amendment of Results of Annual General Meeting
	PTX PTX Ann: Constitution
	PTX PTX Ann: Results of Annual General Meeting
	PTX PTX Ann: AGM Presentation
	PTX PTX Ann: Ceasing to be a substantial holder from AEF
	PTX PTX Ann: Prescient Receives $1.03m R&D Tax Rebate
	PTX PTX Ann: PTX receives New Patent on Companion Diagnostic for PTX-100
	PTX PTX Ann: Expiry of Unlisted Options
	PTX PTX Ann: September 2020 Quarterly Update and Appendix 4C

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
21-Aug	$0.08	599,958	0.00 (1.30%)
20-Aug	$0.08	2,246,217	0.00 (2.53%)
19-Aug	$0.08	165,661	0.00 (1.25%)
18-Aug	$0.08	1,382,412	-0.01 (5.88%)
17-Aug	$0.09	693,160	0.00 (1.16%)
14-Aug	$0.09	609,467	+0.00 (3.61%)
13-Aug	$0.08	498,004	0.00 (1.19%)
12-Aug	$0.08	233,969	0.00 (2.33%)
11-Aug	$0.09	173,885	+0.00 (1.18%)
10-Aug	$0.09	941,072	0.00 (3.41%)
07-Aug	$0.09	327,039	0.00 (1.12%)
06-Aug	$0.09	186,097	0.00 (2.20%)
05-Aug	$0.09	282,221	0.00 (1.09%)
04-Aug	$0.09	1,978,935	+0.01 (8.24%)
03-Aug	$0.09	650,579	0.00 (0.00%)
3 up, 11 down, and 1 flat days

Prescient Therapeutics Health Care
Cancer Therapeutics

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Prescient Therapeutics Health Care Cancer Therapeutics

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Prescient Therapeutics Health Care
Cancer Therapeutics